acebutolol has been researched along with Lupus Erythematosus, Systemic in 6 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acebutolol is a beta blocking agent that induces in C57Bl/6 mice a polyclonal activation of lymphocytes (PAL)." | 1.28 | The beta-blocker acebutolol down modulates the spontaneous polyclonal activation of lymphocytes in NZB X NZW lupus mice. ( Alary, C; Appolinaire-Pilipenko, S; f1noist, H; Fournié, GJ; In, S; Lulé, J; Oksman, F; Rollet, C, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Record, NB | 1 |
| Simon, P | 1 |
| Aubert, F | 1 |
| Boivin, M | 1 |
| Bonn, F | 1 |
| Mery, JP | 1 |
| Stevens, MB | 1 |
| In, S | 1 |
| Lulé, J | 1 |
| f1noist, H | 1 |
| Oksman, F | 1 |
| Appolinaire-Pilipenko, S | 1 |
| Alary, C | 1 |
| Rollet, C | 1 |
| Fournié, GJ | 1 |
| Querin, S | 1 |
| Feuillet-Fieux, MN | 1 |
| Jacob, L | 1 |
| Niel, G | 1 |
| Bach, JF | 1 |
| Hourdebaigt-Larrusse, P | 1 |
| Ziza, JM | 1 |
| Grivaux, M | 1 |
6 other studies available for acebutolol and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Acebutolol-induced pleuropulmonary lupus syndrome.
Topics: Acebutolol; Antibodies; Antibodies, Antinuclear; DNA; Humans; Lupus Erythematosus, Systemic; Male; M | 1981 |
[Lupus syndrom induced by a beta-blocker].
Topics: Acebutolol; Adult; Female; Humans; Lupus Erythematosus, Systemic | 1981 |
Drug-induced lupus.
Topics: Acebutolol; Adult; Aged; Antibodies, Antinuclear; Blood Sedimentation; Female; Humans; Lupus Erythem | 1992 |
The beta-blocker acebutolol down modulates the spontaneous polyclonal activation of lymphocytes in NZB X NZW lupus mice.
Topics: Acebutolol; Age Factors; Albuminuria; Animals; Antibodies, Antinuclear; Cells, Cultured; Down-Regula | 1991 |
Specificity of acebutolol-induced antinuclear antibodies.
Topics: Acebutolol; Antibodies, Antinuclear; Antibody Specificity; DNA; DNA, Single-Stranded; Histones; Huma | 1986 |
[A new case of lupus induced by acebutolol].
Topics: Acebutolol; Aged; Antibodies, Antinuclear; Humans; Lupus Erythematosus, Systemic; Male | 1985 |